医学
关节病
关节炎
磁共振成像
内科学
骨关节炎
外科
病理
放射科
替代医学
作者
Alexandre Leuci,Marie Robert,Laurie Josset,Michael A. Marano,Philippe Connes,Stéphanie Désage,Sandrine Meunier,Anne Lienhart,Yesim Dargaud
标识
DOI:10.1111/1756-185x.15061
摘要
Abstract Introduction Hemophilia is a rare constitutional bleeding disorder due to a deficiency in Factor VIII or Factor IX. Recurrent hemarthroses, one of the major complications of the disease, lead to hemophilic arthropathy, a disabling condition that requires early diagnosis. Traditionally, clinical examination and plain film radiography have been used to diagnose hemophilic arthropathy. Magnetic resonance imaging (MRI) and ultrasound can be more useful for diagnosing soft‐tissue changes. However, but each of these methods has limitations and diagnosis of arthropathy can be delayed. Aim The aim of this project was to assess plasmatic biomolecules indicative of osteo‐cartilaginous damage in patients with hemophilia with or without known arthropathy, in order to improve the diagnosis of this major complication of the disease. Methods In this monocentric retrospective study, 40 patients with hemophilia A or B, for whom a plasma sample was available, provided informed consent for further analyses (multiplex immunoassays and ELISA) and collection of relevant clinical information in their medical files. Correlations were sought for between biomarkers of interest and the severity of joint lesions assessed according to Pettersson's radiologic score. Results Two biomarkers were identified, respectively SDF‐1α and COMP. Their plasmatic levels were significantly increased in patients with arthropathy compared to controls and patients without arthropathy. These values correlated significantly with the Pettersson score in patients under regular prophylaxis. Conclusion Two plasma biomarkers have been identified that could help assess the presence and severity of hemophilic arthropathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI